Patent details

Basic Information

Publication number:

EP3055409

PCT Application Number:

US2014059993

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP148518418

PCT Publication Number:

WO2015054554

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METABOLICALLY OPTIMIZED CELL CULTURE

French Title of Invention:

CULTURE CELLULAIRE À MÉTABOLISME OPTIMISÉ

German Title of Invention:

METABOLISCH OPTIMIERTE ZELLKULTUR

SPC Number:

Dates

Filing date:

10/10/2014

Grant date:

25/04/2018

EP Publication Date:

17/08/2016

PCT Publication Date:

16/04/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/04/2018

EP B1 Publication Date:

25/04/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/10/2018

Expiration date:

10/10/2034

Renunciation date:

Revocation date:

17/09/2024

Annulment date:

Owner

From:

18/04/2018

 

 

Name:

Regeneron Pharmaceuticals, Inc.

Address:

777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:

KIM, Ann

Address:

United States (US)

2

Name:

JOHNSON, Amy

Address:

United States (US)

3

Name:

LAWRENCE, Shawn

Address:

United States (US)

Priority

Priority Number:

201361889815 P

Priority Date:

11/10/2013

Priority Country:

United States (US)

Classification

IPC classification:

C12N 5/02; C12N 5/16;

Publication

European Patent Bulletin

1

Issue number:

201817

Publication date:

25/04/2018

Description:

Grant (B1)

2

Issue number:

202447

Publication date:

20/11/2024

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1